Joseph Garcia from Blake, Cassels & Graydon LLP has advised NervGen Pharma. Mintz has advised the underwriters. NervGen Pharma has completed a public offering valued at...
NervGen Pharma Completes $60 Million Public Offering
Eupraxia Pharmaceuticals Closes US$63.2 Million Public Offering
Mintz and Stikeman Elliott LLP have advised the underwriters. Troutman Pepper and Blake, Cassels & Graydon LLP have advised Eupraxia Pharmaceuticals. Eupraxia Pharmaceuticals Inc., a clinical-stage...


























